Literature DB >> 8782113

Neuronal mediators of inhibitory junction potentials and relaxation in the guinea-pig internal anal sphincter.

M G Rae1, T C Muir.   

Abstract

1. Inhibitory junction potentials (IJPs) and relaxations evoked in response to field stimulation (supramaximal voltage, 0.1 ms, single stimulus and 5 stimuli at 5-40 Hz) of non-adrenergic non-cholinergic (NANC) nerves with atropine and phentolamine (each 1 microM) were measured in the guinea-pig internal anal sphincter (gpIAS). The mean resting membrane potential was -44.2 +/- 0.2 mV (n = 1119 cells from 260 preparations). 2. NANC nerve stimulation evoked frequency-dependent IJPs (19.7 +/- 1.1 mV, n = 165, 33 tissues to a single stimulus) and relaxations. IJPs consisted of two tetrodotoxin (1 microM)-sensitive components: one was abolished by apamin (0.3 microM) and the P2-purinoceptor antagonist suramin (100 microM); the other, smaller in amplitude, was sensitive to inhibitors of nitric oxide synthase (NOS, e.g. L-NAME, 100 microM) and the nitric oxide (NO) scavenger oxyhaemoglobin (HbO, 10 microM). 3. ATP (1 mM), vasoactive intestinal polypeptide (VIP, 0.01-0.25 microM) and pituitary adenylate cyclase-activating peptide (PACAP(1-27), 0.84 microM) each hyperpolarized and relaxed the gpIAS; only ATP responses resembled the evoked IJPs in time course. 4. The guanylyl cyclase inhibitor LY83583 (10 microM) abolished apamin-insensitive IJPs and relaxations. The cGMP phosphodiesterase inhibitor M&B 22948 (30 microM) and 8-Br-cGMP (100 microM) each hyperpolarized the gpIAS. 5. Two components comprise the IJP and relaxation evoked in response to NANC nerve stimulation in the gpIAS. One, sensitive to apamin, resembles the response to ATP and is modulated by purinoceptor antagonists; the other, apamin and suramin insensitive, is inhibited by NO antagonists.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8782113      PMCID: PMC1158934          DOI: 10.1113/jphysiol.1996.sp021400

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  26 in total

1.  LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase.

Authors:  A Mülsch; R Busse; S Liebau; U Förstermann
Journal:  J Pharmacol Exp Ther       Date:  1988-10       Impact factor: 4.030

2.  Non-cholinergic excitatory and inhibitory junction potentials in the circular smooth muscle of the guinea-pig ileum.

Authors:  R A Bywater; G S Taylor
Journal:  J Physiol       Date:  1986-05       Impact factor: 5.182

Review 3.  Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP.

Authors:  R M Rapoport; F Murad
Journal:  J Cyclic Nucleotide Protein Phosphor Res       Date:  1983

4.  Neuroeffector transmission in the guinea-pig internal anal sphincter: an electrical and mechanical study.

Authors:  S P Lim; T C Muir
Journal:  Eur J Pharmacol       Date:  1986-08-22       Impact factor: 4.432

Review 5.  Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function.

Authors:  J Fahrenkrug
Journal:  Digestion       Date:  1979       Impact factor: 3.216

6.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta.

Authors:  W Martin; G M Villani; D Jothianandan; R F Furchgott
Journal:  J Pharmacol Exp Ther       Date:  1985-03       Impact factor: 4.030

7.  Contribution of ATP and nitric oxide to NANC inhibitory transmission in rat pyloric sphincter.

Authors:  P Soediono; G Burnstock
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

8.  VIP as a possible neurotransmitter of non-cholinergic non-adrenergic inhibitory neurones.

Authors:  R K Goyal; S Rattan; S I Said
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

9.  Purine receptors in the guinea-pig internal anal sphincter.

Authors:  A Crema; G M Frigo; S Lecchini; L Manzo; L Onori; M Tonini
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

10.  Mechanisms underlying the electrical and mechanical responses of the guinea-pig internal anal sphincter to field stimulation and to drugs.

Authors:  S P Lim; T C Muir
Journal:  Br J Pharmacol       Date:  1985-10       Impact factor: 8.739

View more
  7 in total

1.  Comparison of inhibitory neuromuscular transmission in the Cynomolgus monkey IAS and rectum: special emphasis on differences in purinergic transmission.

Authors:  C A Cobine; M McKechnie; R J Brookfield; K I Hannigan; K D Keef
Journal:  J Physiol       Date:  2018-10-13       Impact factor: 5.182

Review 2.  Regulation of basal tone, relaxation and contraction of the lower oesophageal sphincter. Relevance to drug discovery for oesophageal disorders.

Authors:  R Farré; D Sifrim
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

3.  Apamin- and nitric oxide-sensitive biphasic non-adrenergic non-cholinergic inhibitory junction potentials in the rat anococcygeus muscle.

Authors:  S Selemidis; J Ziogas; T M Cocks
Journal:  J Physiol       Date:  1998-12-15       Impact factor: 5.182

4.  Functional role of vasoactive intestinal polypeptide in inhibitory motor innervation in the mouse internal anal sphincter.

Authors:  K D Keef; S N Saxton; R A McDowall; R E Kaminski; A M Duffy; C A Cobine
Journal:  J Physiol       Date:  2013-01-21       Impact factor: 5.182

5.  Electrical properties of detrusor smooth muscles from the pig and human urinary bladder.

Authors:  Hikaru Hashitani; Alison F Brading
Journal:  Br J Pharmacol       Date:  2003-06-09       Impact factor: 8.739

Review 6.  The purinergic neurotransmitter revisited: a single substance or multiple players?

Authors:  Violeta N Mutafova-Yambolieva; Leonie Durnin
Journal:  Pharmacol Ther       Date:  2014-06-02       Impact factor: 12.310

Review 7.  Purinergic signalling in the gastrointestinal tract and related organs in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-12-04       Impact factor: 3.765

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.